CA
Can-Fite BioPharma Ltd.
CANF · AMEX
$2.28 +1.79% (+$0.04)
1M -33.13%
Market Cap $2.96M
P/E Ratio -
Div. Yield -
ROE 201.06%
Piotroski F-Score Weak
2/9Valuation
56 /100
Fair P/B 0.53x
P/S 7.31x
EV/EBITDA N/A
Growth
15 /100
Declining Book val. growth 7.73%
Rev. growth 20.42%
FCF growth N/A
Profitability
20 /100
Weak Net margin 2,426.67%
Op. margin 2,456.79%
FCF margin 2,210.12%
Quality
1 /100
Poor ROE 201.06%
ROA 103.30%
Asset turnover 0.04x
Debt
100 /100
Low Current ratio 3.46x
Debt/Equity 0.01x
Net debt/EBITDA N/A
Stability
20 /100
Unstable Rev. volatility 17.71%
EPS volatility 611.96%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre CANF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Motti Farbstein
Employees
5
Headquarters
Ramat Gan
Evenimente viitoare
01 APR.
Earnings
Upcoming earnings report